登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C23H36N2 · xHCl
化学文摘社编号:
分子量:
340.55 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
产品名称
MDL-12,330A, Hydrochloride, Cell-permeable and irreversible inhibitor of adenylate cyclase (IC50 = 250 µM).
InChI
1S/C23H36N2.ClH/c1-2-4-6-11-18-23(24-19-12-7-5-3-1)25-22-17-13-16-21(22)20-14-9-8-10-15-20;/h8-10,14-15,21-22H,1-7,11-13,16-19H2,(H,24,25);1H/t21-,22-;/m0./s1
InChI key
CKOPQUCSDBVAQG-VROPFNGYSA-N
assay
≥98% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
DMSO: 10 mg/mL, water: 3 mg/mL, ethanol: 5 mg/mL
shipped in
ambient
Quality Level
General description
Cell-permeable and irreversible inhibitor of adenylate cyclase (IC50 = 250 µM).
Cell-permeable irreversible inhibitor of adenylate cyclase (IC50 = 250 µM).
Biochem/physiol Actions
Cell permeable: yes
Primary Target
Adenylate cyclase
Adenylate cyclase
Product does not compete with ATP.
Reversible: no
Target IC50: 250 µM against adenylate cyclase
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 months at -20°C.
Other Notes
Correia-de-Sa, P., and Ribeiro, J.A. 1994. Eur. J. Pharmacol. 271, 349.
Gorczynska, E., et al. 1994. Endocrinology134, 293.
Delpiano, M.A., and Acker, H. 1991. J. Neurochem.57, 291.
Lippe, C., and Ardizzone, C. 1991. Comp. Biochem. Physiol.99, 209.
Guellaen, G., et al. 1977. Biochim. Biophys. Acta 484, 465.
Gorczynska, E., et al. 1994. Endocrinology134, 293.
Delpiano, M.A., and Acker, H. 1991. J. Neurochem.57, 291.
Lippe, C., and Ardizzone, C. 1991. Comp. Biochem. Physiol.99, 209.
Guellaen, G., et al. 1977. Biochim. Biophys. Acta 484, 465.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持